{"id":21137,"date":"2025-01-10T00:01:52","date_gmt":"2025-01-09T16:01:52","guid":{"rendered":"https:\/\/flcube.com\/?p=21137"},"modified":"2025-01-10T00:01:54","modified_gmt":"2025-01-09T16:01:54","slug":"insilico-medicine-raises-usd-100-million-in-financing-round-led-by-pudong-and-hong-kong","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=21137","title":{"rendered":"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong"},"content":{"rendered":"\n

China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in a new financing round. This marks the first joint investment effort between Shanghai\u2019s Pudong district and Hong Kong in the biopharma sector. The initiative follows a partnership established in December 2023 between Shanghai Pudong Development Group, a state-owned enterprise, and Hong Kong Biotechnology Organization, a non-for-profit organization, to collaborate on technology cooperation channels, industry investment incubation, and more.<\/p>\n\n\n\n

Investor Participation<\/strong>
Other participating investors in this round include Value Partners, Pudong Venture Capital, and returning investor Warburg Pincus, among others. The funds raised will be used to optimize Insilico\u2019s intelligent AI models and algorithms, upgrade and construct the automated robot laboratory, further clinically validate the leading anti-idiopathic pulmonary fibrosis drug ISM001-055, and efficiently promote and continuously explore other self-developed or cooperative drug development pipelines.<\/p>\n\n\n\n

Strategic Partnerships and Expansion<\/strong>
On the same day, Insilico Medicine struck multiple partnerships with the aforementioned investors, indicating its plan to establish its China technology headquarters in Pudong. This move underscores Insilico\u2019s commitment to leveraging the strengths of both regions to accelerate innovation and development in AI-driven biotechnology.<\/p>\n\n\n\n

Significance of the Financing<\/strong>
The USD 100 million financing round highlights Insilico Medicine’s position as a leader in AI-driven drug discovery and development. By securing significant funding and strategic partnerships, the company is well-positioned to advance its pipeline of innovative therapies and enhance its technological capabilities, ultimately improving patient outcomes and contributing to the global biopharma landscape.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in…<\/p>\n","protected":false},"author":1,"featured_media":21138,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[20,164],"class_list":["post-21137","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-finance","tag-insilico-medicine"],"yoast_head":"\nInsilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in a new financing round. This marks the first joint investment effort between Shanghai\u2019s Pudong district and Hong Kong in the biopharma sector. The initiative follows a partnership established in December 2023 between Shanghai Pudong Development Group, a state-owned enterprise, and Hong Kong Biotechnology Organization, a non-for-profit organization, to collaborate on technology cooperation channels, industry investment incubation, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=21137\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong\" \/>\n<meta property=\"og:description\" content=\"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in a new financing round. This marks the first joint investment effort between Shanghai\u2019s Pudong district and Hong Kong in the biopharma sector. The initiative follows a partnership established in December 2023 between Shanghai Pudong Development Group, a state-owned enterprise, and Hong Kong Biotechnology Organization, a non-for-profit organization, to collaborate on technology cooperation channels, industry investment incubation, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=21137\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-09T16:01:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-09T16:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/0927.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong\",\"datePublished\":\"2025-01-09T16:01:52+00:00\",\"dateModified\":\"2025-01-09T16:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137\"},\"wordCount\":265,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/0927.png\",\"keywords\":[\"Finance\",\"Insilico Medicine\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21137#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=21137\",\"name\":\"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/0927.png\",\"datePublished\":\"2025-01-09T16:01:52+00:00\",\"dateModified\":\"2025-01-09T16:01:54+00:00\",\"description\":\"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in a new financing round. This marks the first joint investment effort between Shanghai\u2019s Pudong district and Hong Kong in the biopharma sector. The initiative follows a partnership established in December 2023 between Shanghai Pudong Development Group, a state-owned enterprise, and Hong Kong Biotechnology Organization, a non-for-profit organization, to collaborate on technology cooperation channels, industry investment incubation, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21137\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/0927.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/0927.png\",\"width\":1080,\"height\":720,\"caption\":\"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21137#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong - Insight, China's Pharmaceutical Industry","description":"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in a new financing round. This marks the first joint investment effort between Shanghai\u2019s Pudong district and Hong Kong in the biopharma sector. The initiative follows a partnership established in December 2023 between Shanghai Pudong Development Group, a state-owned enterprise, and Hong Kong Biotechnology Organization, a non-for-profit organization, to collaborate on technology cooperation channels, industry investment incubation, and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=21137","og_locale":"en_US","og_type":"article","og_title":"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong","og_description":"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in a new financing round. This marks the first joint investment effort between Shanghai\u2019s Pudong district and Hong Kong in the biopharma sector. The initiative follows a partnership established in December 2023 between Shanghai Pudong Development Group, a state-owned enterprise, and Hong Kong Biotechnology Organization, a non-for-profit organization, to collaborate on technology cooperation channels, industry investment incubation, and more.","og_url":"https:\/\/flcube.com\/?p=21137","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-01-09T16:01:52+00:00","article_modified_time":"2025-01-09T16:01:54+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/0927.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=21137#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=21137"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong","datePublished":"2025-01-09T16:01:52+00:00","dateModified":"2025-01-09T16:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=21137"},"wordCount":265,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=21137#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/0927.png","keywords":["Finance","Insilico Medicine"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=21137#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=21137","url":"https:\/\/flcube.com\/?p=21137","name":"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=21137#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=21137#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/0927.png","datePublished":"2025-01-09T16:01:52+00:00","dateModified":"2025-01-09T16:01:54+00:00","description":"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in a new financing round. This marks the first joint investment effort between Shanghai\u2019s Pudong district and Hong Kong in the biopharma sector. The initiative follows a partnership established in December 2023 between Shanghai Pudong Development Group, a state-owned enterprise, and Hong Kong Biotechnology Organization, a non-for-profit organization, to collaborate on technology cooperation channels, industry investment incubation, and more.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=21137#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=21137"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=21137#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/0927.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/0927.png","width":1080,"height":720,"caption":"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=21137#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/0927.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21137"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21137\/revisions"}],"predecessor-version":[{"id":21139,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21137\/revisions\/21139"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/21138"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}